Pros
Second Genome is a company that is pioneering new medicines and bioactives from the microbiome. The company thinks differently about drug development. The company believes that harnessing the power of the human microbiome will lead to novel drug discovery and improve human health. The company believes in disruptive innovation, rather than incremental innovation. The way the company disrupts drug discovery innovation is by identifying key products and pathways that bacteria use to impact health vs disease. Once these critical molecules / targets are elucidated, Second Genome then develops these bioactives into conventional drug therapies. It does not use the "bugs (bacteria) as drugs", but rather the bioactive molecules derived from the bugs. These therapeutics have validated targets, take a typical drug like form (NCEs, biologic) and utilize conventional delivery methods. All of these aspects make the therapeutics developed at SG easier to develop, gain regulatory approval, partner and use by patients. The company is powered by top talent, e.g, people in their fields that have made and continue to make strong impacts, whether in research, development, finance or business development.
The company has a fantastic culture of being open, transparent, with significant attention to employee and organizational development. It's leadership is strong with foundations in culture from early biotech companies and years of experience in biotech and pharma company management. Second Genome is an inspiring and fun place to work.
Cons
The company has been growing quite fast and we are getting a bit crowded in our current location. The company is considering several options for its space growth.